Latest Articles

Publication Date
Identification and Validation of Iron Metabolism-Related Biomarkers in Endometriosis: A Mendelian Randomization and Single-Cell Transcriptomics Study.

Studies have shown that the iron concentration in the peritoneal fluid of women is associated with the severity of endometriosis. Therefore, investigation of iron metabolism-related genes (IM-RGs) in endometriosis holds …

Published: Oct. 9, 2025, midnight
Case Report: A patient with lynch syndrome with vaginal endometriosis-associated malignancy and synchronous colonic tubulovillous adenoma.

Endometriosis is a common gynecological condition. However, endometriosis-associated malignancies occur in up to 1% of women with endometriosis. Most cases of endometriosis-associated malignancy occur in the ovary, whereas 20% of …

Published: Oct. 8, 2025, midnight
Mutation profile and molecular heterogeneity in mismatch repair deficient endometrial carcinoma - Frontiers

Mutation profile and molecular heterogeneity in mismatch repair deficient endometrial carcinoma Frontiers

Published: Sept. 25, 2025, 5:47 p.m.
Polymerase Mutations Shape Distinct Cancer Risks - Conexiant

Polymerase Mutations Shape Distinct Cancer Risks Conexiant

Published: Aug. 28, 2025, 4:15 p.m.
Origin of Endometrioid Carcinoma Adjacent to Extraovarian Endometriosis: Detailed Molecular Analyses.

A well-differentiated endometrioid carcinoma at the site of extra-uterine/ovarian endometriosis complicates the differentiation between an uncommon metastatic pattern from a corpus cancer and a synchronous primary tumor originating from adjacent …

Published: July 29, 2025, midnight
Israeli sperm donor’s genetic mutation prompts urgent testing call - www.israelhayom.com

Israeli sperm donor’s genetic mutation prompts urgent testing call www.israelhayom.com

Published: June 5, 2025, 6:27 a.m.
Follow-up of hereditary endometrial carcinoma caused by MLH3 gene mutation: a case report - Frontiers

Follow-up of hereditary endometrial carcinoma caused by MLH3 gene mutation: a case report Frontiers

Published: April 7, 2025, 3:32 p.m.
Biocartis Launches qPCR POLE/POLD1 Mutational Assay - Oncology Nursing News

Biocartis Launches qPCR POLE/POLD1 Mutational Assay Oncology Nursing News

Published: April 4, 2025, 2:04 p.m.
Press Release Biocartis NV: Biocartis Announces Launch of the Brand-New Idylla™ POLE-POLD1 Mutation Assay - GlobeNewswire

Press Release Biocartis NV: Biocartis Announces Launch of the Brand-New Idylla™ POLE-POLD1 Mutation Assay GlobeNewswire

Published: April 2, 2025, 5:01 a.m.
Press Release Biocartis NV: Biocartis Announces Launch of the Brand-New Idylla™ POLE-POLD1 Mutation Assay - TradingView

Press Release Biocartis NV: Biocartis Announces Launch of the Brand-New Idylla™ POLE-POLD1 Mutation Assay TradingView

Published: April 2, 2025, 5 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!